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Abstract 
InvH is an indispensable part of T3SS-I and has a significant role in SPI-I mediated effector protein 
translocation. The InvH mutations have significant effects including reduced secretory and inflamma-
tory responses that result from preventing the normal secretion of several proteins. Our team previous 
studies showed the capable ability of InvH to induce the humoral immune system to prevent almost all 
Salmonella strains infections. The current study aimed to determine all aspects of this protein using 
several bioinformatics tools and find the differences among all Salmonella strains. This data could pave 
the way for further studies about InvH protein and the production of an effective vaccine against Sal-
monella infections. InvH sequences for all Salmonella strains were obtained from GenBank and ana-
lyzed to determine physicochemical properties, B-Cell and T-Cell epitopes, and reliable structures. Re-
sults showed some minimal differences among Salmonella strains. B-Cell and T-Cell epitopes predicted 
by numerous software approved the ability of this protein to induce both humoral and cellular immune 
systems remarkably. This study provided a comprehensive data to determine all features of InvH pro-
tein and our results showed the ability of this protein to design a capable vaccine and the effect of amino 
acid changes on structure and physicochemical properties, and epitopes.  
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1. Introduction 
Each year 1.3 million cases of salmonellosis 
occur globally. Salmonella enterica (S. enterica) 
includes many foodborne pathogens causing sal-
monellosis in developing or developed countries. 
Patterns of salmonellosis in humans include en-
teric fever, gastroenteritis, bacteremia, and 
chronic carries.  Typhoid fever is caused by Sal-
monella enterica serovar Typhi (S. Typhi), and 
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paratyphoid fever is caused by Salmonella para-
typhi (S. paratyphi) A, B, and C. Infection is 
spread by contaminated food or water.  Salmo-
nella Typhimurium (S. Typhimurium) and Sal-
monella enterica serovar Enteritidis (S. Enter-
itidis) cause gastroenteritis via contaminated 
food or water by animal waste. Bacteremia is a se-
rious infection associated with invasive sero-
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types, Salmonella cholearaesuis (S. cholearae-
suis), and Salmonella Dublin (S. Dublin). 
Chronic carriers are major factors to spread Sal-
monellosis in the word [1]. Many Gram-nega-
tive bacteria have a type III secretion system. The 
type-III secretion system-I (T3SS-I) of S. enterica 
is necessary for invasion and translocation effec-
tors proteins from bacteria into host cells. 
Two Salmonella pathogenicity islands of SPI1 
and SPI2 encode structural components, effec-
tors, and regulators of T3SS1 [2, 3]. InvH, a main 
part of T3SS-I, is necessary for the effective per-
formance of Salmonella invasion of epithelial 
cells [4, 5]. Deletion of invH gene is related to re-
duce the invasion efficiency of the bacterium 
compared to the wild-type [5]. Genetic analysis 
has shown the presentation of InvH in many Sal-
monella strains [6]. Immunization with recombi-
nant InvH against S. Enteritidis and S. Typhi in 
animal models has shown its potential as a vac-
cine candidate [7, 8]. Many bioinformatics tools 
have been employed to analyze the properties and 
features of different bacterial and viral genes [9-
13].  
This study aimed to compare experimental 
and bioinformatics data to find epitopes, modifi-
cation sites, and structure analysis that can pro-
vide much useful information on immunogenicity 
and antigenicity of InvH protein.   
2. Material and Methods 
2.1. invH sequence analysis 
For bioinformatics analysis, 6 sequences (full 
length: 444 bp, 148 amino acids) were obtained 
from GenBank (http://www.ncbi.nlm.nih.gov). 
The sequences included were accession number: 
CP009102.1 (S. Typhimurium), accession num-
ber: AOYF01000046.1 (S. Paratyphi B), acces-
sion number: AL513382.1 (S. Typhi), accession 
number: NC_006511.1 (S. Paratyphi A), acces-
sion number: CP000857.1 (S. Paratyphi C), and 
accession number: AM933172.1 (S. Enteritidis).  
2.2. Amino acid changing and Phylogenetic 
trees 
All sequences were translated, edited, and 
aligned using CLC sequence viewer version Beta 
(QIAGEN).  Phylogenic trees were determined by 
neighbor-joining (NJ) methods 1000 times to 
confirm the reliability of phylogenetic trees. Sig-
nal peptide and signal peptide cleavage sites for 
Gram-negative bacteria were determined using 
"SignalP 4.1” at (http://www.cbs.dtu.dk/ser-
vices/SignalP/) [14], "Predisi" (http://www.pre-
disi.de/predisi/startprediction) [15], and "Signal-
BLAST” (http://sigpep.ser-
vices.came.sbg.ac.at/signalblast.html) [16]. 
2.3. InvH physicochemical properties 
"Expasy’s ProtParam" (http://expasy.org/ 
tools/protparam.html) was used to determine 
theoretical isoelectric point (pI), instability index, 
aliphatic index, and grand average hydropathy 
(GRAVY) [17-19]. 
2.4. Immuno-informatic prediction  
"Immuneepitope" (http://tools.immuneep-
itope.org/tools/bcell/iedb_input) was employed 
to determine B-Cell epitopes positions.  Chou and 
Fasman method was used to predict Beta-Turns, 
Karplus and Schulz   for predicting the flexibility; 
Emini method was used for surface accessibility 
prediction, and Parker method for hydrophilicity 
evaluation and Bepipred method to define B-cell 
epitopes using crystal structures. B-cell epitopes 
prediction was based on hydrophilic, flexibility, 
surface accessibility, B-turns, antigenic, exposed 
surface, and Polarity scale methods using BceP-
red software at 
(http://www.imtech.res.in/raghava/bcepred) 
[20], and ABCpred software 
(http://www.imtech.res.in/raghava/abcpred/) 
[21]. T-cell epitope prediction was done by 
"SYFPEITHI" (http://www.syfpei-
thi.de/bin/MHCServer.dll/EpitopePredic-
tion.htm) [22], and "immuneepitope" 
(http://tools.immuneepitope.org/main/tcell/) 
[23]. Antigenicity probability was estimated 
(http://www.ddg-pharmfac.net/vaxijen/Vaxi-
Jen/VaxiJen.html) using VaxiJen software [24]. 
Prediction of IgE epitopes was carried out by Al-
gPred at (http://www.imtech.res.in/raghava/al-
gpred/submission.html) [25]. 
2.5. Disulfide bond prediction 
Disulfide bonds position was predicted using 
DiANNA [26] (http://cla-
vius.bc.edu/~clotelab/DiANNA) and SCRATCH 
[27] (http://scratch.proteomics.ics.uci.edu/). 
2.6. Secondary structure prediction 
Secondary structure was predicted and con-
firmed by SOPMA (http://npsa-pbil.ibcp.fr/cgi-
bin/npsa_automat.pl?page=npsa_sopma.html), 









TASSER) [29-32], Phyre2server 
(http://www.sbg.bio.ic.ac.uk/~phyre) [28], and 
(PS)2 Server [33]   (http://ps2v2.life.nctu.edu.tw) 
were employed to build  3D structures the stereo-
chemistry and quality of the 3D structures mod-
els were evaluated by  Qmean [34, 35]  
(http://swissmodel.expasy.org/qmean/cgi/in-
dex.cgi) and Ramachandran plots were mapped 
by Rampage (http://mor-
dred.bioc.cam.ac.uk/~rapper/rampage.php). 
3. Results  
3.1. Sequences analysis and Phylogenetic 
trees 
The alignment of all sequences is shown in 
Figure 1. Phylogenetic tree for 6 sequences by NJ 
method: two main clades were shown in the tree, 
upper clade is divided into two clusters; in the 
first cluster Paratyphi A and Typhi (with 95 boot-
strap score); in the second cluster Paratyphi C 
and Typhimurium are very close (with 83 boot-
strap score). A clade contains Enteritidis and 
Paratyphi B (Figure 2). Signal peptide prediction 
of each software was similar for all sequences.  
3.2. Amino acid changing 
A comparison of the sequences with S. Typhi 
revealed only 4 amino acid residue changes. 
Changes at positions 36 (K-Q) and 139 (A-S) in S. 
Paratyphi C, amino acid 67 (Q-H) in S. Typhi-
murium, position 146 (A-S) in S. Enteritidis. 
3.3. Protparam results 
Almost the results were similar for all se-
quences except for pI of S. Paratyphi C (Table 1).  
3.4. Immuno-informatics 
Immuneepitopes by Beta-Turn methods de-
termined three positions of 65-72, 70-76 and 126-
132 as B-cell epitopes regions.  Surface Accessi-
bility method showed two regions (87-92 and 
109-114) and flexibility  method showed three re-
gions of 124-131, 87-95 and 106-114, antigenicity 
method indicated region 6-16, hydrophilicity 
method revealed a region (107-114), Bepipred 
(threshold:1) method determined three regions. 
The regions were similar in all sequences. Seven 
parameters of hydrophilicity, flexibility, surface 
accessibility, beta turs, surface exposure and po-
larity were almost similar according to BcePred 
results (Table 2). 
ABCpred results revealed a start position of 
16 meric B-cell epitopes of 97, 46, 89, and 29 were 
similar for all sequences. Prediction of protective 
antigens by "VaxiJen" program was around 0.34 
and was probable non-antigen for all sequences. 
Prediction by mapping of IgE epitopes using "Al-
gPred" software revealed as non-allergen for all 
sequences. HLA-E and HLA B27-5 T-cell epitopes 
results are shown in Table 3. HLA-E epitopes in 
all sequences were similar and HLA-B27-5 
epitope regions were similar in all sequences ex-
cept for S. Paratyphi C in which region 27 in 
HLA-B*27:05 was absent. The 8-14 meric 
epitopes were similar in all sequences except for 
S. Paratyphi C in which region 27 in HLA-
B*27:05 was absent. 
3.5. Disulfide bond prediction 
Three disulfide positions (7, 48, and 85) were 
predicted by "DiANNA" and 4 positions (7, 16, 48, 
and 85) by "scratch". Positions 7, 16, 48, and 85 
were conserved for disulfide bonds. 
3.6. Secondary and tertiary structures predic-
tion 
Percentages of secondary structures by 
"SOPMA" are given in Table 4. The results were 
almost similar in all sequences. The secondary 
structures are shown in Figure 3.  We could not 
construct a valid structure for InvH protein using 
all programs. 
4. Discussion 
Cloning and molecular characterization of 
InvH were performed in 1993 [6]. The role of this 
protein in adherence and invasion to epithelial 
cell culture was determined in previous studies 
[6]. InvH is necessary for intestinal secretory and 
inflammatory responses, bovine macrophages ly-
sis, and secretion of Salmonella effecter proteins 
by type III secretion system (TTSS). InvH is an 
important part of the needle complex of TTSS and 
is required for efficient assembly of the organelle. 
InvH  is  present  in  all  Salmonella  strains  ex-
cept  Salmonella  Heidelberg  (S. Heidelberg)  
and  Salmonella  enterica  subspecies  arizonae 
(S. arizonae).  InvH  is  highly  conserved  in  all  
strains. 





Figure 1. The alignment of 
all used sequences 
 
Figure 2. Phylogenic tree 
for all sequences by Neigh-
bor-Joining method with 
100 bootstrap score 
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Table 4. Percentages of the secondary structures for all sequence 
Sequences 




50.34, 4.76, 2.72, 42.18 
Paratyphi B 51.02, 4.76, 2.72,  41.50 
Typhi 51.02, 4.76, 2.72,  41.50 
Paratyphi A 51.02, 4.76, 2.72,  41.50 
Paratyphi C 51.02, 4.76, 2.72,  41.50 
Enteritidis 51.02, 4.76, 2.72,  41.50 
 
 

















7.65 >10 59.76 unstable 78.37 -0.490 
Paratyphi B 7.63 >10 57.64 unstable 78.37 -0.493 
Typhi 7.63 >10 57.64 unstable 78.37 -0.493 
Paratyphi A 7.63 >10 57.64 unstable 78.37 -0.493 
Paratyphi C 6.72 >10 60.26 unstable 77.69 -0.507 
Enteritidis 7.63 >10 60.63 unstable 77.69 -0.510 
 
Table 2. BcePred analysis of all sequences 
 Se-
quences  











22-23, 60-62, 70-72, 
106-109, 125-127, 
29-30, 33-39, 58-65, 68-69, 
72-75, 87-94, 102-115, 127-
128 
65-71 










22-23, 60-62, 70-72, 
106-109, 125-127, 
29-30, 33-39, 58-65, 67-70, 
72-75, 87-94, 102-115, 127-
128 
66-71 









22-23, 60-62, 70-72, 
106-109, 125-127, 
29-30, 33-39, 58-65, 67-70, 
72-75, 87-94, 102-115, 127-
129 
66-71 










22-23, 60-62, 70-72, 
106-109, 125-127, 
29-30, 33-39, 58-65, 67-70, 
72-75, 87-94, 102-115, 127-
130 
66-71 










22-23, 60-62, 70-72, 
106-109, 125-127, 
29-30, 33-35, 58-65, 67-70, 
72-75, 87-94, 102-115, 127-
131 
66-71 









22-23, 60-62, 70-72, 
106-109, 125-127, 
29-30, 33-39, 58-65, 67-70, 
72-75, 87-94, 102-115, 127-
130 
66-71 








Table 3. HLA-E*01:01, HLA-B*27:05 T-cell epitope 
regions in selected Sequences 
HLA Start Length Sequences 
HLA-E*01:01 35 8 QKEQLANA 
HLA-E*01:01 66 8 HPQYMRSK 
HLA-E*01:01 102 9 PVFLLIGCA 
HLA-E*01:01 9 10 NANSIDECQS 
HLA-E*01:01 41 10 EKYKQTKEQA 
HLA-E*01:01 86 10 HPQYMRSKED 
HLA-E*01:01 102 11 HPQYMRSKEDE 
HLA-E*01:01 102 12 QPGAQKEQLANA 
HLA-E*01:01 31 12 HPQYMRSKEDEE 
HLA-E*01:01 102 13 NKSLSNQNADNSA 
HLA-E*01:01 61 13 HPQYMRSKEDEEQ 
HLA-E*01:01 66 14 DECQSLPYVPSDLA 
HLA-E*01:01 102 8 QKEQLANA 
HLA-E*01:01 46 8 HPQYMRSK 
HLA-E*01:01 55 9 PVFLLIGCA 
HLA-B*27:05 106 10 M R S K E D E E Q L 
HLA-B*27:05 2 10 K K F Y S C L P V F 
HLA-B*27:05 129 10 K N L S I Y Q T L L 
HLA-B*27:05 12 10 L L I G C A Q V P L 
HLA-B*27:05 27 10 K P V Q Q P G A Q K 
HLA-B*27:05 89 10 K Q T K E Q A L T F 
HLA-B*27:05 3 9 K F Y S C L P V F 
HLA-B*27:05 19 9 V P L P S S V S K 
HLA-B*27:05 121 9 K V L L E P G S K 
 
 





















Three residual changes were determined be-
tween S. typhimurium and S. choleraesuis [6]. In 
this study, we found 4 residual changes and the 
phylogenic tree showed high similarity between 6 
sequences because of the similarity in InvH se-
quences. 
S. Typhimurium, S. Paratyphi A, S. Para-
typhi B, S. Paratyphi C, S. Typhi, and S. Enter-
itidis are important in foodborne diseases. In our 
previous studies, the presentation of InvH on 
bacterial surface and antibody interaction with 
this protein was validated. 
Theoretical pI for all sequences was 7.63 ex-
cept for S. Paratyphi C, which was 6.72. This 
could be attributed to a change in acidic amino 
acid to a basic one (lysine to glutamine 36).  
Instability index provided estimated protein 
stability of 77.7 to 78.3 in a test tube that showed 
this protein is an unstable protein (Instability in-
dex of <40 is regarded). 
The aliphatic index was 78 for all sequences 
which is a positive factor for the thermostability 
of globular proteins and depends on aliphatic side 
chains (alanine, valine, isoleucine, and leucine). 
The aliphatic index of a protein is defined as 
the relative volume occupied by aliphatic side 
chains (alanine, valine, isoleucine, and leucine) 
and it may be regarded as a positive factor for the 
increase of the thermostability of globular pro-
teins. The aliphatic index of a protein is calcu-
lated according to the following formula: Ali-
phatic index = X(Ala) + a * X(Val) + b * ( X(Ile) + 
X(Leu) ) where X(Ala), X(Val), X(Ile), and X(Leu) 
are mole percent (100 X mole fraction) of alanine, 
valine, isoleucine, and leucine. The coefficients a 
and b are the relative volume of valine side chain 
(a = 2.9) and of Leu/Ile side chains (b = 3.9) to 
the side chain of alanine.  
Hydropathicity index was around -0.6 for all 
sequences shows hydrophilicity of the protein. 
Hydrophilicity of protein parts is a positive patent 
for immune proteins because these parts are al-
most exposed and have the potential of interac-
tion with immunoglobulins.     
Signal peptide cleavage sites and signal pep-
tide region prediction by three programs shows 
three (19, 26, and 15) different sites. "Predisi" re-
sults were more reliable and similar to experi-
mental results. The mutation in nucleotide 106 (A 
to C) brought about amino acid change (K-Q 36) 
in S. Paratyphi C, nucleotide 199 (G to T) brought 
about amino acid change (Q-H 67) in S. Typhi-
murium. The mutation in nucleotide 415 (G to T) 
changed the amino acid 139 from A-S in S. Para-
typhi C, and that in nucleotide 436 (G to T) 
changed the amino acid 67 (Q-H) in S. Enter-
itidis. 
B-cell epitopes prediction by "Immuneep-
itope" and six other methods showed some potent 
similar regions. A combination of the results of all 
methods showed four potent B-cell regions (65-
Figure 3. Secondary struc-
tures of all sequences pre-
dicted and validated by 
"SOMPA". Blue: helix, 
Red: strand, Purple: coil 
and Green: beta turn. A: 
Typhimurium, B: Paratyphi 
B, C: Typhi, D: Paratyphi 
A, E: Paratyphi C, F: Enter-
itidis 
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76, 87-95, 106-114, and 124-132). B-cell epitopes 
by BcePred showed similar regions in all se-
quences. ABCpred regions (29-45, 46-62, 89-105, 
and 97-113) were similar in all sequences. Im-
muneepitope, BcePred, and ABCpred showed the 
most potent B-cell epitope of 86-115 for InvH pro-
tein.  Region 86-115 contains the best potential in 
terms of hydrophilicity, flexibility, surface acces-
sibility, surface exposed position, polarity, and 
linear B-cell epitopes prediction. This region con-
tains almost alpha helix and random coil struc-
tures.  
Immunization of mice by recombinant InvH 
showed a significant rise of IgG and humoral re-
sponse and protective immunization against S. 
Typhi and S. Enteritidis [7, 8] confirming our im-
mune-informatics analysis. "VaxiJen" showed 
InvH protein as probable non-antigen. AlgPred 
determined InvH as non-allergen. 
HLA-E binds nonamer peptides derived from 
bacterial proteins and triggers CD8-mediated ly-
sis and IFN- production when exposed to infected 
targets, raising the possibility that this novel ef-
fector mechanism might contribute to host de-
fense against intracellular bacterial infections. 
Salmonella OMP peptides binding to HLA-
B*27:05 were identified to modulate the host-mi-
crobe interaction and HLA-B27 confers a very 
strong genetic predisposition to the development 
of reactive arthritis after infection by bacteria 
such as S. Typhimurium [36].  
Our results showed 9 HLA-B*27:05 and 15 
HLA-E T-cell epitopes regions. We, however, 
found two 9 meric T-cell epitopes (102-111 and 
55-64) that indicated a good potential of InvH to 
stimulate cell-mediated immune system. 
Disulfide bonds are important in determining 
the functional linkages and stability of proteins. 
SS bonds were analyzed using two reliable pro-
grams. Four cysteine amino acids making two di-
sulfide bonds in InvH contributed to protein sta-
bility. Amino acid 16, 48 were located on coil 
structure, 7 on strand structure, and 58 was on 
helix structure and any of them were not located 
on selected B-cell epitope region (86-115).     
Secondary structure in InvH protein con-
tained almost alpha helix and random coil. Re-
sults of all the sequences were similar except for 
S. Typhimurium in which region 60-80 helix was 
changed to random coil because of the change in 
amino acid (Q-H 67). We, however, could not 
achieve a proper 3D model for InvH, in spite of 
using three popular and reliable programs.  
The limited number of sequences and the 
number of bioinformatics software employed are 
the main limitation of the present study. In addi-
tion, other Salmonella strains can be added for 
further studies.   
To sum up, it can be concluded that the find-
ings of the present study provided valuable data 
about InvH protein which can be used to design a 
novel vaccine against all Salmonella strains as 
well as all physicochemical features of this pro-
tein were defined which can be useful to express 
this protein in available hosts.   
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